Wee Loon Ong
@weeloonong
GU Radiation Oncologist, @AlfredHealth | Adjunct Professor, @MonashSTM
Victorian Rad Onc 2020/2021/2022 cohort at RANZCR annual ceremony #RANZCR2022 @RANZCRcollege @FacRadOncology @PeterMacRadOnc @AlfredHealth @ONJCancerCentre

Please join our esteemed international RO speakers in Melbourne in October for #RANZCR2025! Early bird registrations close 15 July 2025. ranzcrasm.com @RANZCRcollege @NiuSanford @reshmajagsi @SahgalArjun @AmarUKishan @SimonLo21054188 @jmmrad @BoekeSimon @GkikaEleni2
As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025! @AmarUKishan @SahgalArjun @NiuSanford @fabiomoraesmd
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a phase 3 thelancet.com/journals/lanon… Authors: @alison_tree, @nickva1, & @EmmaHall71 @royalmarsden, @Accuray, @ICR_London
New review led by @DeepOnco of @royalmarsdenNHS outlines global trends and evolving diagnostics, treatment, and surveillance of #ProstateCancer. Read: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… @PCaParker @AmarUKishan @VedangMurthy @nickva1 @alison_tree @APCCC_Lugano @ICR_London
📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity
@weeloonong leads pub in @EurUrolOncol for #PATRIOT (#SBRT weekly vs every other day treatment for favourable risk #prostatecancer ) No stat diff in bioc fail (mFU of 91mo) Planning to combine with @ZilliThomas #NOVALIS study (same design) free link👉tinyurl.com/yyhd69c2
As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025! @AmarUKishan @SahgalArjun @NiuSanford @fabiomoraesmd
We hope everyone enjoyed the ASM in Perth! Please tag us in any photos or memories from your time there. #RANZCR2024 With many thanks to our sponsors, delegates and all our guests. We look forward to welcoming you next year in Melbourne for #RANZCR2025
excited that we are now offering prostate SABR at @BarwonHealth Andrew Love Cancer Center, benefiting men with prostate cancer in western regional Victoria! @VicGovDH @TargetingCancer
Another major milestone for @AlfredHealth Radiation Oncology - now offering prostate SABR at our satellite site at Latrobe Regional Health @LRH_Hospital, making treatment more convenient for men with prostate cancer in regional Victoria! @MonashPCCC (photo with patient consent)
Delighted to share the results of #PACE B trial, published in @NEJM today 5 fraction SBRT is non inferior to CRT! nejm.org/media/doi/full… @alison_tree @ICR_CTSU @EmmaHall71 @royalmarsdenNHS @DrAndrewLoblaw @cpeedell @DrTolan @ProfJOSullivan @DrSuneil_PCa
In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: nej.md/4dBI8UN
After 4 years of the GÖTEBORG-2 trial, MRI-targeted biopsy led to less detection of clinically insignificant prostate cancer than systematic biopsy without compromising the detection of cancer that may affect survival. Read the full trial results: nej.md/4ewOjKT
🙏Thanks to mentoring by @AmarUKishan , stats support by Tahmineh Romero, and contributions by coauthors 🙏 Thanks to funding from RANZCR-TROG research grant @RANZCRcollege @TROGfightcancer 🙏Thanks to patients from multiple trials who contributed data for the analysis
Pleased to share the newest MARCAP publication, out in @EUplatinum -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by @weeloonong and Tahmineh Romero Free share link: authors.elsevier.com/a/1joOX14kplyz…
Thomas Kennedy leads 10y prostate #SBRT outcomes from 3 different prospective studies now epub at #RedJ @IJROBP doi.org/10.1016/j.ijro… Great biochemical control to 15 years and only 1% chance of mets! Note 10% of UIR pts received ADT and none had whole pelvic RT (-> #PR24)
#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients @DrTolan @alison_tree @cpeedell @DrAndrewLoblaw @EmmaHall71 @ProfJOSullivan authors.elsevier.com/sd/article/S03…
Online First: #Palliative #radiotherapy versus best supportive care in patients with painful #hepaticcancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study #radonc thelancet.com/journals/lanon…
Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine @JCOOP_ASCO ascopubs.org/doi/pdf/10.120…
Another major milestone for @AlfredHealth Radiation Oncology - now offering prostate SABR at our satellite site at Latrobe Regional Health @LRH_Hospital, making treatment more convenient for men with prostate cancer in regional Victoria! @MonashPCCC (photo with patient consent)
Massive team effort to start @AlfredHealth Prostate Stereotactic Ablative Body Radiotherapy (SABR) program - first public centre in Victoria to offer prostate SABR as standard of care treatment options on CT-Linac, cutting down treatment from 20 to 5 visits for prostate cancer!
Team Aussie 🇦🇺 at #ReCOG. Definitely lots of collective work/ opportunities (eg reirradiation registry) to improve ReRT Down Under! @HardcastleNick @RANZCRCollege
It’s a full house as we kick off this international effort to tackle the complex problem of re-irradiation. Thank you to our guests and experts from around the world to @UMich. Thrilled to host this incredibly important event! @ASTRO_org @aapmHQ @ESTRO_RT @UMichRadOnc
Good to see RADICALS-HD in print. THanks to numerous colleagues and collaborators over 20 years authors.elsevier.com/sd/article/S01…
Good catch-up and moderating @ISRSy #ISRSUSA2024 GU prostate SABR session with @DrCorreaRO, co-fellows @Sunnybrook @UofTDRO @DrAndrewLoblaw
Excellent GU abstracts presented @ISRSy #ISRSUSA2024 Congress. #SBRT @DrCorreaRO and @weeloonong moderating.
Final anlyses of the @Sunnybrook GLIO study that proved tumour migration during fractionated rads for high grade glioma and now reporting prognostic relevance. Congrats to our prior fellow Dr. Wee Ong from 🇦🇺 and supervisor Dr. Myrehaug. pubmed.ncbi.nlm.nih.gov/38561051/